As the year draws to a close, medium and small drugmakers in India have a deadline coming up in less than two months as the country moves to secure the production of safe and quality medicines. After ...
Low compliance by the country’s 8,500 small and medium enterprises (MSMEs) manufacturing pharmaceuticals would raise the risk ...
Automated cell therapy manufacturing pioneer Cellares has hit a key milestone, gaining a current Good Manufacturing Practice (cGMP) stamp of approval for its Cell Shuttle factory-in-a-box, which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback